163 related articles for article (PubMed ID: 18780572)
1. [Urgent states in hematology: acute promyelocytic leukemia--principles of diagnosis].
Schwarz J; Kacírková P; Marková J; Mikulenková D; Marinov I; Ballingová I; Michalová K
Vnitr Lek; 2008; 54(7-8):728-44. PubMed ID: 18780572
[TBL] [Abstract][Full Text] [Related]
2. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
3. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
[TBL] [Abstract][Full Text] [Related]
4. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.
Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G
Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253
[TBL] [Abstract][Full Text] [Related]
5. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
7. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.
Piedras J; López-Karpovitch X; Cárdenas R
Cytometry; 1998 Aug; 32(4):286-90. PubMed ID: 9701397
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of dual fusion PML/RARalpha translocation DNA probe (D-FISH) in acute promyelocytic leukemia.
Wan TS; So CC; Hui KC; Yip SF; Ma ES; Chan LC
Oncol Rep; 2007 Apr; 17(4):799-805. PubMed ID: 17342318
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of acute promyelocytic leukemia in children.
Mantadakis E; Samonis G; Kalmanti M
Acta Haematol; 2008; 119(2):73-82. PubMed ID: 18285695
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
[TBL] [Abstract][Full Text] [Related]
13. The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?
Exner M; Thalhammer R; Kapiotis S; Mitterbauer G; Knöbl P; Haas OA; Jäger U; Schwarzinger I
Cytometry; 2000 Apr; 42(2):106-9. PubMed ID: 10797447
[TBL] [Abstract][Full Text] [Related]
14. [Myeloid/natural killer cell acute leukemia resembling acute promyelocytic leukemia].
Wang JN; Hou YQ; Zhang LB; Bao HY; Song M; Meng QQ; Fu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):830-4. PubMed ID: 23998568
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
17. A complex, four-way variant t(15;17) in acute promyelocytic leukemia.
Yoo SJ; Seo EJ; Lee JH; Seo YH; Park PW; Ahn JY
Cancer Genet Cytogenet; 2006 Jun; 167(2):168-71. PubMed ID: 16737919
[TBL] [Abstract][Full Text] [Related]
18. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
Korístek Z; Mayer J
Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
[TBL] [Abstract][Full Text] [Related]
19. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
20. PML-RARalpha fusion gene transcripts and biological features in acute promyelocytic leukemia patients.
Melo RA; de Vasconcellos JF; Melo FC; Machado CG; Lacerda TM; Souto FR
Clin Lab Haematol; 2006 Apr; 28(2):126-9. PubMed ID: 16630218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]